Analyze Diet
Journal of the American Veterinary Medical Association2007; 231(8); 1225-1230; doi: 10.2460/javma.231.8.1225

Management and complications of anesthesia for transvenous electrical cardioversion of atrial fibrillation in horses: 62 cases (2002-2006).

Abstract: To describe management of anesthesia for transvenous electrical cardioversion (TVEC) in horses and report perianesthetic complications. Methods: Retrospective case series. Methods: 62 horses with atrial fibrillation and without underlying cardiac disease and 60 horses without atrial fibrillation. Methods: Medical records of horses with atrial fibrillation anesthetized for TVEC were reviewed, as were records of horses without atrial fibrillation anesthetized for magnetic resonance imaging (MRI). The TVEC group horses were compared with MRI group horses for incidence of intraoperative bradycardia and use of inotropic drugs. Data obtained included patient signalment, weight, duration of anesthesia, heart rate and arterial blood pressure during anesthesia, anesthetic drugs administered, mode of ventilation, perioperative complications, and quality of recovery. Results: The TVEC group horses were > 1 year of age and were predominantly Standardbreds. The TVEC group horses underwent a total of 76 anesthetic episodes. For 40 (52.6%) anesthetic episodes, horses received xylazine only for premedication, and for 26 (34.2%) anesthetic episodes, horses received xylazine and butorphanol. Induction of anesthesia consisted of ketamine administration in various combinations with diazepam and guaifenesin for 74 (97.4%) anesthetic episodes and ketamine alone for 2 (2.6%). Bradycardia in horses was encountered during 15 of 76 (19.7%) anesthetic episodes. Minor signs of possible postanesthetic myopathy occurred following 6 (7.9%) anesthetic episodes. No significant difference was found between TVEC and MRI group horses regarding incidence of bradycardia and inotropic drug administration. Conclusions: Short-duration anesthesia for TVEC of atrial fibrillation in horses without underlying cardiac disease was a safe procedure.
Publication Date: 2007-10-17 PubMed ID: 17937553DOI: 10.2460/javma.231.8.1225Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates how anesthesia was managed during a procedure called transvenous electrical cardioversion (TVEC), used to treat atrial fibrillation in horses. It also provides details about any complications that occurred during these procedures. The data from horses undergoing this procedure was compared to those of another group of horses that were being anesthetized for magnetic resonance imaging (MRI).

Methods and Participants

  • This is a retrospective case study where the researchers reviewed medical records from various cases. Those who participated included 62 horses with atrial fibrillation with no underlying heart disease and 60 horses with no atrial fibrillation. The first group went through the TVEC procedure while the second group was undergoing MRI.
  • Details such as patient signalment, weight, duration of anesthesia, heart rate and arterial blood pressure during anesthesia, anesthetic drugs administered, method of ventilation, complications around the time of the operation, and the quality of recovery were collected and noted from the medical records.

Findings and Results

  • The data showed that the horses in the TVEC group were primarily Standardbreds and over a year old. These horses went through 76 episodes of anesthesia.
  • For more than half of the anesthetic incidents, only xylazine was used as a pre-medication. In about one third of the cases, both xylazine and butorphanol were used. Ketamine, often in combination with diazepam and guaifenesin, served as the induction drug in almost all the anesthesia episodes.
  • Bradycardia, or rather slow heart rate, was observed in about one fifth of the anesthesia episodes.
  • There were minor signs of possible postanesthetic myopathy, a muscular disease usually characterized by muscle inflammation and weakness, in almost 8% of the anesthetic occurrences.
  • When the TVEC group was compared to the MRI group, no significant differences were noticed in terms of the occurrence of bradycardia and the use of inotropic drugs, which increase the contractility of the heart.

Conclusion

  • The researchers conclude that short-duration anesthesia for TVEC of atrial fibrillation in horses with no underlying heart disease is relatively safe. This integral piece of information serves as a valuable contribution to veterinary anesthesia, especially when treating horses with atrial fibrillation.

Cite This Article

APA
Bellei MH, Kerr C, McGurrin MK, Kenney DG, Physick-Sheard P. (2007). Management and complications of anesthesia for transvenous electrical cardioversion of atrial fibrillation in horses: 62 cases (2002-2006). J Am Vet Med Assoc, 231(8), 1225-1230. https://doi.org/10.2460/javma.231.8.1225

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 231
Issue: 8
Pages: 1225-1230

Researcher Affiliations

Bellei, Maria Helena M
  • Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
Kerr, Carolyn
    McGurrin, M Kimberly J
      Kenney, Daniel G
        Physick-Sheard, Peter

          MeSH Terms

          • Age Factors
          • Anesthesia / adverse effects
          • Anesthesia / veterinary
          • Animals
          • Atrial Fibrillation / therapy
          • Atrial Fibrillation / veterinary
          • Electric Countershock / methods
          • Electric Countershock / veterinary
          • Electrocardiography / veterinary
          • Female
          • Horse Diseases / therapy
          • Horses
          • Magnetic Resonance Imaging / veterinary
          • Male
          • Retrospective Studies
          • Safety
          • Treatment Outcome